BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• 

  Layoff Tracker

  Novo workforce down 13,000

  Follow along as BioSpace tracks job cuts and restructuring initiatives.

  September 23, 2026

   · 

  95 min read

   · 

  BioSpace Editorial Staff
• 

  IPO

  2026 IPO stock tracker: How newly public biotechs are performing

  BioSpace is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.

  September 23, 2026

   · 

  1 min read

   · 

  Gabrielle Masson
• 

  C-suite

  ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s hands

  After achieving clinical validation earlier this year, ReCode Therapeutics has called up a new CEO to take on the mission of advancing programs for cystic fibrosis and primary ciliary dyskinesia through the clinic.

  September 23, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  Swiss Bioscience and OrganTech sign MOU to explore strategic collaboration in hair regeneration in Europe

  Swiss Bioscience selected as OrganTech’s preferred strategic partner in Europe for regulatory development, GMP manufacturing, clinical research, and potential commercialization of the conditioned medium technology.

  September 23, 2026

   · 

  1 min read
• Press Releases

  Sydnexis Announces Royalty Agreement with Ligand for Ryjunea®

  September 23, 2026

   · 

  2 min read
• Press Releases

  Longhorn Vaccines and Diagnostics Appoints Vijay Singh, PhD, as Chief Scientific Officer

  September 23, 2026

   · 

  2 min read
• Press Releases

  Epitel’s REMI Neuro Monitoring System Selected for the FDA’s READI-Home Innovation Challenge

  September 23, 2026

   · 

  2 min read
• Press Releases

  Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026

  September 23, 2026

   · 

  20 min read
• 

  China

  China’s surging biotech sector represents both competition and lifeline for the US

  As Chinese companies push beyond “me-too” drugs and the country lays out a new five-year plan targeting a $522 billion–strong biotech industry by 2030, experts say more predictable funding and regulation could help the U.S. maintain its edge.

  September 23, 2026

   · 

  8 min read

   · 

  Shawna Williams
• Press Releases

  Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts

  September 23, 2026

   · 

  3 min read